Chemoinformaics analysis of Methyl Rosamarinate
| Molecular Weight | 374.345 | nRot | 6 |
| Heavy Atom Molecular Weight | 356.201 | nRig | 15 |
| Exact Molecular Weight | 374.1 | nRing | 2 |
| Solubility: LogS | -2.337 | nHRing | 0 |
| Solubility: LogP | 2.197 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 45 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 2 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 19 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 8 | No. of Arom Bond | 12 |
| nHA | 8 | APOL | 50.1483 |
| nHD | 4 | BPOL | 23.2657 |
| QED | 0.342 |
| Synth | 2.943 |
| Natural Product Likeliness | 1.047 |
| NR-PPAR-gamma | 0.951 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.004 |
| Pgp-sub | 0.004 |
| HIA | 0.058 |
| CACO-2 | -5.208 |
| MDCK | 0.0000118 |
| BBB | 0.036 |
| PPB | 0.955754 |
| VDSS | 0.424 |
| FU | 0.0322185 |
| CYP1A2-inh | 0.823 |
| CYP1A2-sub | 0.272 |
| CYP2c19-inh | 0.518 |
| CYP2c19-sub | 0.052 |
| CYP2c9-inh | 0.767 |
| CYP2c9-sub | 0.87 |
| CYP2d6-inh | 0.407 |
| CYP2d6-sub | 0.574 |
| CYP3a4-inh | 0.492 |
| CYP3a4-sub | 0.199 |
| CL | 16.928 |
| T12 | 0.957 |
| hERG | 0.032 |
| Ames | 0.281 |
| ROA | 0.444 |
| SkinSen | 0.956 |
| Carcinogencity | 0.21 |
| EI | 0.791 |
| Respiratory | 0.069 |
| NR-Aromatase | 0.565 |
| Antiviral | Yes |
| Prediction | 0.553566 |